These findings not only support dominant but complicated roles of immunity in host defense and tumor pathogenesis, but also provide a molecular and cellular basis to target myeloid NF-κB2 to restore antitumor immunity for lung cancer prevention and treatment. The gene discussed is NFKB2; the disease is lung carcinoma.